Table 2.
Basic patient characteristics and results of hormonal testing in FHA women with and without PCOM
| FHA without PCOM (n = 37) | FHA with PCOM (n = 27) | Controls (n = 32) | p | |
|---|---|---|---|---|
| Age (years) | 26 (21;30) | 26 (21;28) | 26 (23;28) | 0.731 |
| BMI (kg/m2) | 20.0 (18.5;21.6) | 20.4 (18.6;23.2) | 21.5 (19.6;23.6) | 0.131 |
| TSH (IU/mL) | 1.78 (1.17;2.04) | 1.49 (1.08;2.36) | 1.41 (1.05;1.93) | 0.400 |
| FSH (mIU/mL) | 4.0 (2.6;6.1) | 4.6 (3.5;6.5) | 5.7 (4.4;7.6) | 0.034 |
| LH (mIU/mL) | 2.6 (1.2;4.9)b | 2.6 (1.3;6.3)c | 4.7 (3.4;7.0)b c | 0.001 |
| Prolactin (ng/mL) | 7.9 (6.5;12.2)b | 9.3 (6.6;13.1) | 11.8 (9.0;15.4)b | 0.013 |
| Estradiol (pg/mL) | 23 (16;35)b | 30 (11;45)c | 71 (50;97)b c | < 0.001 |
| Testosterone (pg/mL) | 0.22 (0.13;0.30) | 0.22 (0.15;0.30) | 0.25 (0.17;0.31) | 0.695 |
| Androstenedione (ng/mL) | 1.29 (0.93;2.10) | 1.65 (1.09;2.62) | 1.54 (1.18;2.04) | 0.269 |
| DHEAS (µg/mL) | 2.01 (1.47;3.25 | 2.33 (1.56;2.84) | 2.18 (1.76;2.74) | 0.926 |
| SHBG (nmol/L) | 79.4 (60.3;120.9) | 68.3 (37.7;99.8) | 81.2 (61.;104.5) | 0.144 |
| AMH (ng/mL) | 2.03 (1.40;2.50)a b | 6.38 (4.34;10.10)a c | 3.08 (2.24;4.10)b c | < 0.001 |
Variables are expressed as median (IQR); non-parametric Anovas with post hoc Bonferonni correction were perfomed
asignificantly different between FHA without PCOM and FHA with PCOM
bsignificantly different between FHA without PCOM and controls
csignificantly different between FHA with PCOM and controls